GORE HELEX Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients Foramen Ovale (PFO) (the REDUCE Study)

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/108/30/21

Funding

  • W L Gore Association Inc: $105,992.00